SCHEMBL2804714

SCHEMBL2804714

COc1ccc(CCNc2ncc3c(n2)-c2ccccc2C(c2ccccc2)C3)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.50
FGFR2 P21802 2/20 0.50
CSF1R P07333 1/20 0.50
FGFR3 P22607 1/20 0.50
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.46
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 2/20 0.45
KDM4E B2RXH2 1/20 0.45
TTR P02766 1/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
RAD52 P43351 1/20 0.45
APP P05067 6/20 0.44
BCHE P06276 5/20 0.44
ACHE P22303 5/20 0.44
IGF1R P08069 1/20 0.43
CCNT1 O60563 1/20 0.43
CCNA2 P20248 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803989 0.93 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3LMNA
SCHEMBL2803237 0.92 FGFR1 (0.52) FGFR1FGFR2CSF1RFGFR3LMNA
SCHEMBL2806906 0.89 CSF1R (0.51) FGFR1FGFR2CSF1RFGFR3LMNA
SCHEMBL2808244 0.86 FGFR1 (0.59) FGFR1FGFR2CSF1RFGFR3APP
SCHEMBL2802654 0.86 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3TSHR
SCHEMBL2806030 0.85 FGFR1 (0.44) FGFR1FGFR2CSF1RFGFR3LMNA
SCHEMBL2804578 0.85 FGFR1 (0.46) FGFR1FGFR2CSF1RFGFR3LMNA
SCHEMBL2804023 0.84 FGFR1 (0.54) FGFR1FGFR2CSF1RFGFR3
SCHEMBL2805563 0.83 FGFR1 (0.55) FGFR1FGFR2CSF1RFGFR3
SCHEMBL2807724 0.82 FGFR1 (0.45) FGFR1FGFR2CSF1RFGFR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885FGFR2 511/4885CSF1R 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.